The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $182.18

Today's change+0.63 +0.35%
Updated July 21 4:00 PM EDT. Delayed by at least 15 minutes.
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $182.18

Today's change+0.63 +0.35%
Updated July 21 4:00 PM EDT. Delayed by at least 15 minutes.

Thermo Fisher Scientific Inc Hits New 52-week High

Thermo Fisher Scientific Inc closed up Friday by (U.S.)$0.63 or 0.35% to (U.S.)$182.18 and setting a new 52-week high. Over the last five days, shares have gained 0.68% and 29.11% year to date. Shares have outperformed the S&P 500 by 2.44% during the last year.

Key company metrics

  • Open(U.S.) $181.29
  • Previous close(U.S.) $181.55
  • High(U.S.) $182.86
  • Low(U.S.) $181.06
  • Bid / Ask-- / --
  • YTD % change+29.11%
  • Volume786,786
  • Average volume (10-day)1,220,523
  • Average volume (1-month)1,283,785
  • Average volume (3-month)1,469,658
  • 52-week range(U.S.) $139.07 to (U.S.) $182.86
  • Beta1.07
  • Trailing P/E33.20×
  • P/E 1 year forward19.73×
  • Forward PEG1.82×
  • Indicated annual dividend(U.S.) $0.60
  • Dividend yield0.33%
  • Trailing EPS(U.S.) $5.49
Updated July 21 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+11.60%

Based on its net profit margin of 11.60%, Thermo Fisher Scientific Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.53%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedApr 01, 201704/01/2017Dec 31, 201612/31/2016Oct 01, 201610/01/2016Jul 02, 201607/02/2016
Revenue4,7654,9534,4914,535
Total other revenue--------
Total revenue4,7654,9534,4914,535
Gross profit2,1932,2792,0542,079
Total cost of revenue2,5732,6742,4372,457
Total operating expense4,1434,2013,9503,898
Selling / general / administrative1,3001,2571,2121,219
Research & development215213183182
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)555711739
Other operating expenses, total--------
Operating income622753541638
Interest income (expense), net non-operating-135-131-113-119
Gain (loss) on sale of assets--------
Other--------
Income before tax503652428521
Income after tax551633474517
Income tax, total-4919-464
Net income551630474517
Total adjustments to net income--------
Net income before extra. items551633474517
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items551633474517
Inc. avail. to common incl. extra. items551630474517
Diluted net income551630474517
Dilution adjustment--------
Diluted weighted average shares394397397397
Diluted EPS excluding extraordinary itemsvalue per share1.401.591.191.30
Dividends per sharevalue per share0.150.150.150.15
Diluted normalized EPSvalue per share1.491.981.381.40